Technical Analysis for PANC - Panacos Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade F 0.0001 -66.67% -0.0002
PANC closed down 66.67 percent on Monday, August 5, 2019, on 51 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical PANC trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Reversal New Lows Setup Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%

Older signals for PANC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Panacos Pharmaceuticals, Inc. (Panacos) is a development-stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.
Health Biotechnology Pharmaceutical Industry Health Sciences Hiv Hepatotoxins Lentiviruses Anti Infective Products Human Viral Diseases
Is PANC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.0011
52 Week Low 0.0001
Average Volume 19,772
200-Day Moving Average 0.0
50-Day Moving Average 0.0002
20-Day Moving Average 0.0001
10-Day Moving Average 0.0002
Average True Range 0.0004
ADX 4.01
+DI 77.7778
-DI 100.0
Chandelier Exit (Long, 3 ATRs ) -0.0009
Chandelier Exit (Short, 3 ATRs ) 0.0013
Upper Bollinger Band 0.0002
Lower Bollinger Band 0.0
Percent B (%b) 0.5
BandWidth 200.0
MACD Line -0.0001
MACD Signal Line 0.0
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0004
Resistance 3 (R3) 0.0004 0.0004 0.0004
Resistance 2 (R2) 0.0004 0.0003 0.0004 0.0003
Resistance 1 (R1) 0.0002 0.0002 0.0002 0.0002 0.0003
Pivot Point 0.0002 0.0002 0.0002 0.0002 0.0002
Support 1 (S1) 0.0000 0.0001 0.0000 0.0000 -0.0001
Support 2 (S2) 0.0000 0.0000 -0.0001 -0.0001
Support 3 (S3) -0.0002 0.0000 -0.0002
Support 4 (S4) -0.0002